BioCentury
ARTICLE | Financial News

SutroVax raises $64M

March 21, 2017 12:13 PM UTC

SutroVax Inc. (South San Francisco, Calif.) said Tuesday it raised $64 million, including $60 million in a tranched series B round and $4 million from existing investors to top off its series A round.

New investors Frazier Healthcare Partners and Pivotal bioVenture Partners led the new round, with participation from existing investors Abingworth, Longitude Capital, Roche Venture Fund and CTI Life Sciences. Details regarding the tranches are undisclosed. ...

BCIQ Company Profiles

Vaxcyte Inc.